The incorrect laboratory result. Part 1: Pre- and postanalytical phase;Der "fehlerhafte" laborbefund. Teil 1: Fehlerquellen der prä- und postanalytischen phase

Internist

Volumn 45, Issue 3, 2004, Pages 315-331

  Fiedler, G M ^a   Thiery, J ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Influence factors; Interference factors; Laboratory diagnostics; Quality assurance; Test results

Indexed keywords

ACID PHOSPHATASE; ALANINE AMINOTRANSFERASE; ALCOHOL; ALDOSTERONE; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; ASPARTATE AMINOTRANSFERASE; BICARBONATE; CAFFEINE; CHLORIDE ION; CORTICOTROPIN; CREATINE KINASE; CREATINE KINASE MB; CYCLOSPORIN A; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINE; PROLACTIN; TACROLIMUS; TESTOSTERONE; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL LIPASE; TROPONIN I; TROPONIN T; UNINDEXED DRUG;

AGE; ANALYTICAL ERROR; CLINICAL MEDICINE; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG USE; ELECTROLYTE BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HEMOLYSIS; HORMONE BLOOD LEVEL; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; LIFESTYLE; PLASMA; PREDICTION; PREGNANCY; QUALITY CONTROL; RACE DIFFERENCE; REFERENCE VALUE; REVIEW; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SERUM; SEX DIFFERENCE;

BLOOD CHEMICAL ANALYSIS; CAUSALITY; CROSS-SECTIONAL STUDIES; DIAGNOSTIC ERRORS; DRUG INTERACTIONS; FEMALE; GERMANY; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MALE; PREDICTIVE VALUE OF TESTS; PREGNANCY; QUALITY ASSURANCE, HEALTH CARE; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING;

EID: 1642393209     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-003-1126-y     Document Type: Review

References (16)

1. Narayanan S, Guder W (2002) Präanalytische Variable und ihr Einfluß auf die Qualität von Laboratoriumsbefunden. J Lab Med 26: 263-266
2. Bonini P, Plebani M, Ceriotti F, Rubboli F (2002) Errors in laboratory medicine. Clin Chem 48: 691-698
3. Speicher C (2001) Evidenzbasierte Labordiagnostik. Huber, Bern
4. Guder W, Narayanan S, Wisser H, Zawata B (2000) Proben zwischen Patient und Labor. Der Einfluss präanalytischer Faktoren auf die Qualität von Laboratoriumsbefunden, 2. Aufl. GIT-Verlag, Darmstadt
5. Narayanan S (2000) The preanalytic phase. An important component of laboratory medicine. Am J Clin Pathol 113: 429-452
6. Thomas L (2000) Labor und Diagnose, 5. Aufl. Thomas, Frankfurt
7. Narayanan S (2003) Preanalytical issues in hematology. J Lab Med 27: 243-248
8. Narayanan S (1996) Laboratory markers as an index of aging. Ann Clin Lab Sci 26: 50-59
9. Ruan C,Wu Y, Okada T et al. (2002) Studies on reference intervals for platelet counts in three cities in China and one in Japan. Thromb Haemost 88: 111-114
10. Thiery J, Teupser D, Fiedler GM (2003) Lipide und Störungen des Lipoproteinstoffwechsels. In Renz H (Hrsg) Integrative Klinische Chemie und Laboratoriumsmedizin. de Gruyter, Berlin, S 67-95
11. Young D (1999) Effects of drugs on clinical laboratory tests, 7th edn. American Association for Clinical Chemistry, Washington
12. Armstrong VW (2002) Principles and practice of monitoring immunosuppressive drugs. J Lab Med 26: 27-26
13. Herrmann J, Volbracht L, Haude M, Eggebrecht H, Malyar N, Mann K, Erbel R (2001) Biochemical markers of ischemic and non-ischemic myocardial damage. Med Klin 96: 144-156
14. Wu A, Apple F, Gibler W, Jesse R, Warshaw M, Valdes RJ (1999) National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 45: 1104-1121
15. Guder W, Ehret W, da Fonseca-Wollheim F et al. (2002) Die Qualität diagnostischer Proben. J Lab Med 26: 267-283
16. Neumaier M, Braun A, Wagener C (1998) Fundamentals of quality assessment of molecular amplification methods in clinical diagnostics. International Federation of Clinical Chemistry Scientific Division Committee on Molecular Biology Techniques. Clin Chem 44: 12-26